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Background: A	rapid	growth	 in	 the	number	of	 international	migrants	over	 the	past	
years	has	occurred	with	most	traveling	to	more	affluent	settings.	As	Helicobacter pylori 


















are	 particularly	 at	 risk	 of	 infection	 and	 help	 to	 identify	 gaps	 in	 the	 knowledge	 of	
	migrants’	prevalence	of	infection	globally.











of	 all	 gastric	 cancer	 cases	 in	2012,5	 despite	 the	 fact	 that	 its	 preva-
lence	has	been	declining	 in	 the	 last	 few	decades.6	 Improvements	 in	
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As	the	prevalence	of	infection	remains	generally	higher	in	less	de-
veloped	or	developing	regions	than	in	developed	countries,8	and	most	





tion	 among	migrants,	 taking	 into	 account	 the	 country	 of	 origin	 and	
destination,	through	a	systematic	review	of	published	studies.	We	also	








tify	published	papers	 reporting	H. pylori	 prevalence.	The	 search	ex-
pression	 is	 provided	 in	 the	 systematic	 review	 flowchart	 shown	 in	
Figure	1.	 The	 list	 of	 bibliographic	 references	 of	 the	 original	 reports	













research	 not	 involving	 humans	 (e.g.,	 in	vitro	 or	 animal	 research),	 (3)	
noneligible	 publication	 types	 (reviews,	 editorials,	 comments,	 guide-
lines,	case	reports),	(4)	studies	specifically	evaluating	samples	that	do	
not	allow	 inference	 for	 the	general	population	 (e.g.,	 subjects	under-
going	 endoscopy	 for	 purposes	 other	 than	 screening),	 (5)	 studies	 in-
cluding	only	H. pylori	infected	subjects	(e.g.,	H. pylori	eradication	trials),	
(6)	studies	with	data	not	related	to	H. pylori	prevalence	or	addressing	







presenting	 the	 results	 with	 more	 detail	 (e.g.,	 regarding	 the	 preva-
lence	according	 to	age,	country	of	origin	and	destination,	 including	
region,	or	 according	 to	different	generations),	or	providing	data	 for	
the	largest	sample	was	chosen;	for	cohort	studies	involving	children,	


















The	 prevalence	 of	H. pylori	 in	 different	 generations	 of	migrants	
(age-	specific	 data	 were	 preferred,	 when	 available)	 and	 comparable	
age-	specific	data	for	origin	and	destination	populations	were	retrieved.	





















ArcMap	10.3	 software.	 If	more	 than	one	paper	provided	 the	 same	
geographic	pattern	(same	origin	and	destination	countries),	the	one	
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with	 the	 largest	 sample	 of	migrants	was	 selected	 for	 depiction	 on	
the	map.	Origin	and	destination	countries	for	which	no	age-	specific	








tion	 in	migrants12-39	 from	29	origin	 (15	 from	Africa,	 three	 from	 the	
Americas,	 six	 from	 Asia	 and	 five	 from	 Europe)	 and	 12	 destination	
(three	from	the	Americas,	four	from	Asia	and	Oceania,	and	five	from	
Europe)	 countries.	 The	 reports	 were	 published	 between	 1988	 and	
2014,	and	those	providing	a	period	of	data	collection	refer	to	1989	
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and	2012.	Most	studies	had	a	cross-	sectional	design	and	used	sero-
logic	tests	to	detect	H. pylori	infection	status.
Regarding	 the	 reasons	 for	migration,	 two	 included	 refugees,21,29 
one	was	on	 Irish	 soldiers	assigned	 to	a	mission	 in	Lebanon	 (LBN),14 








studies	 had	 first-	generation	 migrants	 only,12,14-18,21,24-26,29,30,33-36,38 
six	included	first-	and	second-	or	more	generations13,19,23,27,32,37,	and	




The	 nationally	 representative	 prevalences	 of	 H. pylori6 in the 
countries	of	origin	and	destination	are	shown	 in	Figure	2,	with	 lines	
representing	the	difference	in	the	prevalence	of	infection	in	migrants	
in	 relation	 to	origin	and	destination	countries.	The	prevalence	of	H. 
pylori	among	first-	generation	migrants	was	higher	than	the	host	pop-
ulation	in	most	instances.	Compared	to	the	origin,	the	prevalence	was	
higher	 in	 migrants	 from	 the	 African	 continent	 traveling	 to	 Europe,	
similar	 in	 those	going	from	Asia	 to	the	Americas	and	 lower	 in	 those	
migrating	within	the	same	continent	(the	Americas,	Asia	and	Oceania,	
and	Europe).	The	 refugees	moving	 from	China	 (CHN)	 to	 India	 (IND)	
presented	a	prevalence	of	infection	higher	than	both	origin	and	desti-
nation	countries	(77.2%).29	The	studies	with	smaller	sample	sizes,	not	








(Gambia	 [GMB],	 Guinea	 [GIN],	 and	 Guinea	 Bissau	 [GNB]	 to	 Spain	
[ESP])36;	being	higher	than	the	observed	in	the	destination.	The	study	
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TABLE  1 Summary	results	of	the	prevalence	of	H. pylori	infection	(%)	among	migrants,	origin,	and	destination	countries
Origin continent Origin→destination Study identificationa
Prevalence of H. pylori infection (%)
Migrantsb Originc Destinationc
Africa BEN→ESP ① 100.036 75.951 34.052
CIV→ESP ② 100.036 40.653 34.052
CMR→ESP ③ 85.736 80.854 34.052
COD→ESP ④ 100.036 62.455 34.052
CPV→NLD 88.0d19 NA 24.0d19
2G=36.6d19 NA 24.0d19
≥2G=27.920 NA 5.720
ETH→AUS 43.021 NA 9.821
GMB→ESP 100.036 NA 34.052
GHA→ESP 91.736 NA 34.052
GHA→NLD ≥2G=25.031 NA 0.531
GIN→ESP 100.036 NA 34.052
GNB→ESP 100.036 NA 34.052
MAR→NLD ≥2G=6.031 NA 0.531
⑤ 85.7d19 72.756 24.0d19
2G=87.8d19 72.756 24.0d19
≥2G=27.020 NA 5.720
MLI→ESP ⑥ 100.036 44.057 34.052
NGA→ESP ⑦ 89.736 13.658 34.052
SLE→ESP 96.336 NA 34.052
SOM→NLD ≥2G=66.031 NA 0.531








SLV→AUS 40.021 NA 15.621




Asia BGD→GBR ⑨ 66.013 83.463 24.764
2G=81.013 81.663 22.964
CHN→IND 77.229 61.565 44.066
CHN→USA 60.026 62.365 24.026
16.030 27.067 22.517
81.433 56.467 32.0e68
⑪ 63.433 56.467 32.0e68
59.433 56.467 32.0e68
IND→NLD ≥2G=50.031 21.169 0.531
IND→USA 38.515 78.070 0.015
⑫ 46.125 83.371 20.725
(Continues)
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which	included	Irish	soldiers	assigned	to	a	mission	in	LBN	showed	a	







Generation-	specific	 prevalences	 of	 infection	 in	 migrants	 from	
studies	 which	 included	 first-	 and	 second-	 or	 more	 generations	 are	
shown	 in	Figure	3.	The	prevalence	of	H. pylori	among	the	 latter	was	
lower	 than	 the	 first-	generation	 migrants	 in	 all,	 except	 in	 Japanese	
Origin continent Origin→destination Study identificationa
Prevalence of H. pylori infection (%)
Migrantsb Originc Destinationc
JPN→BRA ⑬ 52.627 47.372 90.573
2G=48.227 43.172 88.573




JPN→PER ⑭ 71.437 74.476 75.077
2G=74.237 74.476 75.077
3G=78.637 74.476 75.077
JPN→USA ⑮ 50.032 70.078 32.7e22
≥2G=25.032 70.078 32.7e22
RUS→USA 49.030 50.679 22.517
VNM→AUS ⑯ 68.418 79.280 37.081
18.421 NA 15.621
VNM→KOR ⑰ 55.712 76.480 71.412
Europe ALB→ITA ⑱ 78.738 70.682 51.983
DEU→NLD ≥2G=6.031 NA 0.531
IRL→LBN 31.5	(before)14 43.084 NA
28.5	(after)14 43.084 NA
ROU→USA 20.030 NA 22.517
TUR→DEU ≥2G=30.4e34 44.5e34 13.1e34
≥2G=22.239 25.685 2.339



























With	 respect	 to	 the	 association	between	H. pylori	 infection	 and	










ally	higher	 than	 that	of	 the	destination	country,	while	 compared	 to	
the	 country	 of	 birth,	 it	 varied	 according	 to	 the	 continent	 of	 origin.	
Additionally,	 the	 prevalence	 of	 infection	decreased	with	 successive	
generations,	although	it	remained	higher	than	that	of	the	destination	
in	most	instances.
Generally,	 migrants	 tend	 to	 be	 healthier	 than	 both	 the	 general	





as	 the	 “salmon	 bias	 effect”41).	 Moreover,	 migrants	 generally	 have	
lower	socioeconomic	status,	fewer	social	supports,	language	barriers,	
and	 occasionally	 face	 discrimination	 in	 their	 new	 environments.1,2 












try,	 particularly	when	 the	origin	 country	 is	 of	 high	prevalence,	 such	
as	JPN	 (75%)	 and	MEX	 (66%).6	A	 cross-	sectional	 study	of	Japanese	
migrants	 in	the	USA	showed	that	a	majority	of	those	residing	 in	the	




infection	 frequently	 being	 acquired	 in	 childhood,	 and	 being	 associ-
ated	with	low	socioeconomic	status,	household	crowding	and	having	 
infected	family	members.42,45,46
Relatively	 few	 studies	 presented	 the	 prevalence	 of	 H. pylori in 
first-	generation	migrants	by	duration	of	 residence	 (or	 age	at	 arrival)	
in	the	host	country,	which	could	have	allowed	for	the	assessment	of	
acculturation.	In	these	studies,	we	could	observe	that	those	living	in	
the	 country	 of	 destination	 for	 a	 longer	 period	 of	 time	 had	 a	 lower	

































variations	 in	 the	 prevalence	 of	H. pylori	 have	 been	 established	 not	










To	the	best	of	our	knowledge,	 this	 is	 the	first	systematic	review	
on	the	burden	of	H. pylori	in	migrants	worldwide,	but	a	limitation	re-
lated	with	the	methods	used	for	the	 identification	of	the	potentially	
eligible	 studies	 needs	 to	 be	 addressed.	 The	 fact	 that	 it	 was	 based	
on	 only	 one	 electronic	 database	 may	 have	 contributed	 for	 missing	
studies	potentially	eligible.	However,	as	data	analysis	was	essentially	
descriptive,	no	 important	bias	 is	 expected	 from	 this	methodological	
option.	Furthermore,	our	database	search	relied	on	a	comprehensive	
expression	and	was	complemented	by	citation	tracking,	contributing	
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to	increase	the	sensitivity	of	the	search	and	for	a	comprehensive	over-
view	of	the	prevalence	of	H. pylori	in	migrants.
Our	 study	findings	 are	 consistent	with	what	would	be	expected	
based	on	the	prevalence	of	H. pylori	worldwide.	The	results	of	this	re-
view	provide	insight	into	future	trends	in	the	burden	and	management	
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